[1] Detmar M. The role of VEGF and thrombospondins in skin angiogene sis. J Dermatol Sci, 2000,24(Suppl 1):S78-S84. [2] Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol, 1995,146:1029-1039. [3] Weninger W, Uthman A, Pammer J, et al. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest, 1996.75:647-657. [4] Ballaum C, Weninger W, Uthman A, et al. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol, 1995,104:7-10. [5] Diaz BV, Lenoir MC, Ladoux A,et al. Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids. J Biol Chem, 2000,275:642-650. [6] Weninger W, Rendl M, Mildner M,et al. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal human keratinocytes. J Invest Dermatol, 1998,111:907-911. [7] Gumowski Sunek D, Rizzoli R, Saurat JH. Oral calcium tolerance test in extensive psoriasis treated with topical calcipotriol. Dermatology, 1995,190:43-47. [8] Palleschi GM, Gentili A, Caproni M, et al. Structural alterations of basal keratinocytes and capillary loops in psoriasis during treatment with topical calcipotriol. Acta Derm Venereol Suppl (Stockh), 1994,186:49-51. |